BeOne Medicines
ONC
#651
Rank
$35.73 B
Marketcap
$322.90
Share price
-2.56%
Change (1 day)
55.52%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Number of shares outstanding for BeOne Medicines (ONC)

Number of shares outstanding as of December 2025 : 110,215,515

According to BeOne Medicines's latest financial reports and stock price the company's current number of shares outstanding is 110,215,515. At the end of 2025 the company had 110,215,515 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for BeOne Medicines from 2015 to 2025

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20250.11 B3.72%
20240.10 B1.52%
20230.10 B0.87%
20220.10 B9.19%
202195.02 M4.6%
202090.84 M49.7%
201960.68 M2.19%
201859.38 M30.39%
201745.54 M14.78%
201639.67 M25.9%
201531.51 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Onconova Therapeutics
ONTX
21,043,458-80.91%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
777,154,808 605.12%๐Ÿ‡บ๐Ÿ‡ธ USA